Chinese Journal of Tissue Engineering Research ›› 2019, Vol. 23 ›› Issue (35): 5645-5651.doi: 10.3969/j.issn.2095-4344.1951

Previous Articles     Next Articles

Changes of auditory function and mechanisms in tinnitus rats treated by Wuling Capsule

Mo Binyu1, Wei Tao2, Li Jihui1, Feng Haiyan1, Chen Meiqiu1, Wei Yumei1   

  1.  (1Department of Otorhinolaryngology, 2Department of Neurology, Liuzhou General Hospital, Liuzhou 545006, Guangxi Zhuang Autonomous Region, China)
  • Received:2019-06-04 Online:2019-12-18 Published:2019-12-18
  • Contact: Mo Binyu, Department of Otorhinolaryngology, Liuzhou General Hospital, Liuzhou 545006, Guangxi Zhuang Autonomous Region, China
  • About author:Mo Binyu, Master, Associate chief physician, Department of Otorhinolaryngology, Liuzhou General Hospital, Liuzhou 545006, Guangxi Zhuang Autonomous Region, China
  • Supported by:

     the Research Project of Administration of Traditional Chinese Medicine of Guangxi Zhuang Autonomous Region, No. GZZC16-66 (to LJH)

Abstract:

BACKGROUND: There is no standard cure for tinnitus. Wuling Capsule is a pure Chinese medicine preparation extracted from Wuling Ginseng by modern biological technology. Its composition is Wuling powder, which has the functions of nourishing the heart and calming the nerves, nourishing the kidney and strengthening the brain.
OBJECTIVE: To explore the effect of Wuling Capsule on the auditory function of tinnitus rats and its neuronal plasticity related genes in auditory central ultrastructure and auditory pathway.
METHODS: Seventy-five SPF-level Wistar rats were selected. In addition to the normal group, the other groups of rats were prepared with tinnitus model. After successful modeling, the model group (n=15) and the normal group (n=15) were given normal saline, and the carbamazepine group (n=15) was given carbamazepine solution. The low- and high-dose Wuling Capsule groups were intragastrically administered with 40 and 80 g of Wuling Capsule for 4 weeks. The changes of drinking water inhibition rate Rb, open field behavioral changes, auditory brainstem response threshold, primary auditory cortical pathology, auditory cortex ultrastructural changes, auditory central neurotransmitter γ-aminobutyric acid, 5-hydroxytryptamine were observed in the cortex, cochlear nucleus, inferior colliculus and upper olive.
RESULTS AND CONCLUSION: (1) The mean Rb in the high- and low-dose Wuling Capsule groups and the carbamazepine group in the conditioned reflex period (within 7 days) was significantly lower than that in the model group (P < 0.05). (2) On day 15 after modeling, the total stroke, average speed and erecting times in the model group and each drug-administered group were significantly lower than those in the normal control group, and the number of fecal pellets was significantly higher than that in the normal control group (P < 0.05). After the treatment, the total stroke, average speed and erecting times in the drug-administered groups were significantly higher than those in the model group, and the number of fecal pellets was significantly lower than that in the model group (P < 0.05). (3) Compared with the model group, the levels of γ-aminobutyric acid and 5-hydroxytryptamine in the hypothalamus were significantly increased (P < 0.05), and expression of cytoskeletal proteins in the auditory cortex, inferior colliculus and cochlear nucleus decreased in the low-and high-dose Wuling Capsule groups (P < 0.05). (4) These results indicate that Wuling Capsule significantly reduces the degree of neuronal damage in the auditory pathway of tinnitus rats, improves the ultrastructure of the auditory center, and lowers the auditory brainstem response threshold, thereby improving the auditory function of tinnitus rats and improving the anxiety and depression. The mechanism may be increasing the levels of γ-aminobutyric acid and 5-hydroxytryptamine in the hypothalamus and improving the expression of neuronal plasticity-related genes in the auditory pathway of tinnitus rats. The study was approved by the Ethical Committee of Liuzhou General Hospital, approval No. TRH58689.

Key words:  tinnitus, auditory central ultrastructure, auditory pathway, neuronal plasticity related genes, Wuling Capsule, γ-aminobutyric acid, growth response gene-1, nerve growth related protein, cytoskeletal protein

CLC Number: